(LCTX) Lineage Cell Therapeutics, Inc.
A clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally.
The company has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime , Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Sector: Healthcare
Industry: Biotechnology
Market Cap(M$): 165
52 Week High: 1.67$
52 Week Low: 0.53$
Forward PE: -6.11
Analysts Recommendations
2015-12-22, Oppenheimer, Outperform
2016-02-19, Chardan Capital, Buy
2016-09-23, Ladenburg Thalmann, Buy
2019-03-18, Raymond James, Outperform